Cargando…

Short-chain fatty acids in the context of Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Metzdorf, Judith, Tönges, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343296/ https://www.ncbi.nlm.nih.gov/pubmed/33642384 http://dx.doi.org/10.4103/1673-5374.308089

Ejemplares similares

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Gut microbiota–derived short-chain fatty acids and kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2017)

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

Perspective: Physiologic Importance of Short-Chain Fatty Acids from Nondigestible Carbohydrate Fermentation
por: Alexander, Celeste, et al.
Publicado: (2019)

Epigenetic connection between gut microbiota-derived short-chain fatty acids and chromatin histone modification in kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2022)

Mitochondria in the context of Parkinson's disease
por: Villacé, Patricia, et al.
Publicado: (2017)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
por: Aho, Velma T. E., et al.
Publicado: (2021)

Short-chain fatty acids in diseases
por: Zhang, Dan, et al.
Publicado: (2023)

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson’s Disease Modelling
por: Schikora, Justus, et al.
Publicado: (2021)

Antibody-based immunotherapies for Parkinsonian syndromes
por: Tönges, Lars, et al.
Publicado: (2019)

Roles of short-chain fatty acids in kidney diseases
por: Li, Ling-Zhi, et al.
Publicado: (2019)

The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids
por: Sam, Qi Hui, et al.
Publicado: (2021)

Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation
por: Baert, Florence, et al.
Publicado: (2021)

Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson’s disease patients
por: Wu, Gang, et al.
Publicado: (2022)

Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
por: YAMAMURA, Ryodai, et al.
Publicado: (2019)

The role of short-chain fatty acids in inflammatory skin diseases
por: Xiao, Xianjun, et al.
Publicado: (2023)

Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease
por: Shin, Yoonhwa, et al.
Publicado: (2023)

Regulation of Inflammation by Short Chain Fatty Acids
por: Vinolo, Marco A.R., et al.
Publicado: (2011)

Short-chain fatty acids in cancer pathogenesis
por: Feitelson, Mark A., et al.
Publicado: (2023)

Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease
por: Chen, Szu-Ju, et al.
Publicado: (2022)

Randomised clinical study: inulin short‐chain fatty acid esters for targeted delivery of short‐chain fatty acids to the human colon
por: Polyviou, T., et al.
Publicado: (2016)

Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
por: Mi, Na, et al.
Publicado: (2023)

Short-chain fatty acids as modulators of redox signaling in health and disease
por: González-Bosch, Carmen, et al.
Publicado: (2021)

Evaluation and comparison of short chain fatty acids composition in gut diseases
por: Niccolai, Elena, et al.
Publicado: (2019)

Regulatory role of short-chain fatty acids in inflammatory bowel disease
por: Zhang, Zhilin, et al.
Publicado: (2022)

Short-Chain Fatty Acid Receptors and Cardiovascular Function
por: Lymperopoulos, Anastasios, et al.
Publicado: (2022)

Regulation of short-chain fatty acids in the immune system
por: Liu, Xiao-feng, et al.
Publicado: (2023)

The Implication of Short-Chain Fatty Acids in Obesity and Diabetes
por: Anachad, Oumaima, et al.
Publicado: (2023)

The Role of Short-Chain Fatty Acids in Acute Pancreatitis
por: Yan, Xiaxiao, et al.
Publicado: (2023)

Short-chain fatty acids are potential goalkeepers of atherosclerosis
por: Feng, Yu, et al.
Publicado: (2023)

Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
por: Nishiwaki, Hiroshi, et al.
Publicado: (2020)

Perspective: Role of Micronutrients and Omega-3 Long-Chain Polyunsaturated Fatty Acids for Immune Outcomes of Relevance to Infections in Older Adults—A Narrative Review and Call for Action
por: Eggersdorfer, Manfred, et al.
Publicado: (2022)

Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases
por: Sturm, Eva Maria, et al.
Publicado: (2021)

The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
por: Mizuno, Miho, et al.
Publicado: (2017)

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease
por: Cong, Jing, et al.
Publicado: (2022)

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
por: Lu, Yingdong, et al.
Publicado: (2022)

Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)
por: Włodarczyk, Jakub, et al.
Publicado: (2022)

Enzymatic measurement of short-chain fatty acids and application in periodontal disease diagnosis
por: Hatanaka, Kazu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1sb49eu8v09dprbtdleg89mrr9